ℹ️ No matches surfaced in the limited public sources we cover (sanctions, screening, insolvency, control). This is an automated indicator — not an exhaustive check, a credit decision, or a guarantee, and absence of a match does not mean none exists. Verify against the official register.
Think this is wrong? This is an automated estimate — request a human review or correction.
SUTRO BIOPHARMA, INC.
Company
Overview
SUTRO BIOPHARMA, INC. is a operating registered in SOUTH SAN FRANCISCO, United States. With reported revenue of 11.3M USD in 2019. Its TraceComp score of 49 (D) indicates elevated risk requiring further due diligence.
Company Information
- Registration Number
- 0001382101
- Legal Form
- Company
- Activity
- Biological Products, (No Diagnostic Substances)
- Address
- South-San-Francisco
Financial Profile
Latest filed accounts: FY 2019 · most recent available in public filings
Multi-year financials & ratios
1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Research Output
Active research organization. 143 publications · 24,204 citations · h-index 69 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Medicine (81%) · Biochemistry, Genetics and Molecular Biology (14%) · Chemistry (5%).
See full research profile — top researchers & publications →
Source: OpenAlex (CC0). Objective publication & citation counts.
Patent Portfolio
Active patent holder. 53 patents · 52 active · 53 granted in the USPTO/EPO record.
See full patent portfolio — most-cited inventions & inventors →
Source: USPTO / EPO open patent data. Objective bibliographic counts.
Risk Signals
No adverse legal events have been recorded for this company.
- Net loss reported in FY 2019
Similar Companies
Data Sources & Freshness
Data sourced from: official public registries. Profile completeness: 70%.